PlainRecalls
FDA Drug Moderate Class II Terminated

Aripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2921-03

Reported: April 12, 2023 Initiated: March 20, 2023 #D-0490-2023

Product Description

Aripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2921-03

Reason for Recall

cGMP Deviations

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
3 bottles
Distribution
RemedyRepack distributed product to consignees nationwide within the United States
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Aripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2921-03. Recalled by RemedyRepack Inc.. Units affected: 3 bottles.
Why was this product recalled?
cGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on April 12, 2023. Severity: Moderate. Recall number: D-0490-2023.